Accelera Pharma
Accelera Pharma is a privately held Canadian pharmaceutical distribution company founded in 2018 and based in Mississauga, Ontario. With 11–50 employees, it focuses on dermatology products and secure online transactions within specialty pharma distribution.
- Company typePrivate
- Founded2018
- HeadquartersMississauga, Canada
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Accelera Pharma does
Accelera Pharma is a privately held Canadian pharmaceutical distribution company headquartered in Mississauga, Ontario, founded in 2018. Per the firmographic profile, the company specializes in pharmaceutical distribution with a focus on dermatology products and secure online transactions, suggesting a niche specialty-distribution positioning rather than broad-line wholesale.
The company's stated scope is 11–50 employees, placing it in the small-business tier relative to the broader Canadian pharmaceutical distribution sector. The website (apcipharma.com) currently displays only a verification/loading placeholder rather than substantive company content, and no management team, product catalog, technology stack, certifications, partnerships, or pricing information was resolvable from the input sources.
No funding rounds, M&A activity, geographic footprint, ownership structure, or revenue figures are disclosed. The "secure online transactions" descriptor implies some form of e-commerce or controlled-substance ordering infrastructure, but no first-party evidence of the underlying mechanics, customer segments served, or commercial channels is available. Commercial, operational, and technological visibility into the business is materially constrained by the absence of verifiable primary content.
Accelera Pharma firmographics
Firmographics- Name
- Accelera Pharma
- Website
- https://apcipharma.com
- Company type
- Private
- Founded year
- 2018
- Headcount range
- 11–50 employees
- Short description
- Accelera Pharma is a privately held Canadian pharmaceutical distribution company founded in 2018 and based in Mississauga, Ontario. With 11–50 employees, it focuses on dermatology products and secure online transactions within specialty pharma distribution.
- Ownership category
- akta.pro rank
Accelera Pharma industry classification
Industry- Product category
- Specialty Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)
- akta.pro secondary industries
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Health, Wellness & Pharmacy Marketplaces (CRAFABAF)
Keywords
Where Accelera Pharma is headquartered
LocationHeadquarters
- HQ city
- Mississauga
- HQ country
- Canada
- HQ region
- North America
Markets served
Accelera Pharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel
Accelera Pharma product offering
Product offeringCore offering
Accelera Pharma distributes pharmaceutical products with a focus on dermatology, conducting business through secure online transactions. The company operates as a specialty pharmaceutical distributor serving the dermatology therapeutic area.
Differentiator
Problem solved
Functional benefit
Products and services
- Dermatology Pharmaceutical Distribution
Companies that use Accelera Pharma
Customer profileIdeal customer profiles1 record
Accelera Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Accelera Pharma competitors and assessment
Company assessmentBroad incumbents
- Cardinal Health: Cardinal Health is a major US-headquartered pharmaceutical distributor and healthcare services company with global operations. Comparable as one of the largest pharmaceutical wholesalers whose scale economies and contracting power set the benchmark any smaller specialty distributor must work against.
- AmerisourceBergen (now Cencora): Cencora (formerly AmerisourceBergen) is a global pharmaceutical distributor and solutions provider serving manufacturers, pharmacies, and providers. As one of the Big Three North American pharma wholesalers, it represents the broad incumbent benchmark on distribution scale, dermatology line coverage, and manufacturer relationships.
- McKesson Canada: McKesson is one of Canada's largest pharmaceutical wholesalers, distributing prescription drugs and health products across retail pharmacies, hospitals, and clinics. It is the dominant incumbent in Canadian pharma distribution that any specialist distributor like Accelera would compete against on supplier access and logistics scale.
Direct peers
- Galderma: Galderma is the world's largest independent dermatology-focused pharmaceutical company, offering prescription and aesthetic dermatology products. Comparable as a dermatology specialty pharma whose Canadian distribution channel partner profile Accelera would either align with or compete against for dermatology prescribing relationships.
- Kohl & Frisch: Kohl & Frisch is a Canadian-owned pharmaceutical distributor serving retail pharmacies across Canada. Comparable as a domestic Canadian pharma wholesaler of similar smaller-mid scale competing for retail pharmacy contracts in the same market geography as Accelera.
- Bausch Health: Bausch Health is a global specialty pharmaceutical company with a strong dermatology franchise (Bausch + Lomb skincare, prescription derms). Comparable as a vertically adjacent specialty pharma participant whose dermatology product portfolio a Canadian dermatology-focused distributor would handle or compete against in formulary access.
Regional players
- Shoppers Drug Mart (Loblaw): Shoppers Drug Mart is Canada's largest retail pharmacy chain, dispensing prescription drugs and selling pharmacy/health merchandise nationally. Comparable as a major Canadian pharmacy and drug retail channel that a Canadian pharmaceutical distribution specialist would interact with as both a customer and an adjacent competitor.
- Apotex: Apotex is Canada's largest generic pharmaceutical manufacturer, headquartered in the Toronto/Mississauga area. Comparable as a Canadian pharma company operating in the same therapeutic categories including dermatology generics, providing both a potential upstream supplier and adjacent benchmark for category depth.
- Lupin Pharmaceuticals Canada: Lupin Pharmaceuticals operates in Canada distributing dermatology and specialty generics. Comparable as an international specialty/generic pharma with a Canadian dermatology footprint that could share distribution channels with Accelera or compete for similar dermatology accounts.
Emerging players
- PharmaDerm (a division of Valeant/Bausch): PharmaDerm is the branded dermatology prescription division of Bausch Health focused on acne, psoriasis, and atopic dermatitis. Comparable as a dermatology-specialty pharma channel participant whose product set overlaps directly with what Accelera would distribute.
Market position
Strengths3 records
Weaknesses4 records
Key risks5 records
Key highlights4 records
Customer concentration
Accelera Pharma social profiles
Digital presenceAccelera Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Accelera Pharma leadership team
Management profileNumber of profiles
Accelera Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Accelera Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Accelera Pharma
What does Accelera Pharma do?
Accelera Pharma distributes pharmaceutical products with a focus on dermatology, conducting business through secure online transactions. The company operates as a specialty pharmaceutical distributor serving the dermatology therapeutic area.
When was Accelera Pharma founded?
Accelera Pharma was founded in 2018. It employs 11 to 50 people.
Where is Accelera Pharma based?
Accelera Pharma is headquartered in Mississauga, Canada, in the North America region.
Who are Accelera Pharma's main competitors?
Broad incumbents on record are Cardinal Health, AmerisourceBergen (now Cencora) and McKesson Canada. Direct peers are Galderma, Kohl & Frisch and Bausch Health. Regional players are Shoppers Drug Mart (Loblaw), Apotex and Lupin Pharmaceuticals Canada. PharmaDerm (a division of Valeant/Bausch) is listed as an emerging player.
Does Accelera Pharma have an API?
No public API is recorded for Accelera Pharma.
What industry is Accelera Pharma in?
Accelera Pharma's product category is Specialty Pharmaceutical Distribution. Its primary akta.pro industry code is CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 42421 and its SIC code is 5122.